NCT03957304View on ClinicalTrials.gov

Intranasal Dexmedetomidine Dose-finding Study

PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

February 20, 2020

Primary Completion Date

March 30, 2022

Study Completion Date

March 30, 2022

Conditions
Laceration Repair
Interventions
DRUG

Dexmedetomidine

Intranasal dexmedetomidine

Trial Locations (1)

N6A5W9

London Health Sciences Centre, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT03957304 - Intranasal Dexmedetomidine Dose-finding Study | Biotech Hunter | Biotech Hunter